Position in TSHA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$296,235
+$101,790 QoQ
Shares Held
43,500
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#130
of 208 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in TSHA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST MANHATTAN CO. LLC. holds $1,927,732 across 8 Biotechnology names. TSHA ranks #3 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,560 | $774,898 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
11,146 | $394,456 | |
| 3 | TSHA |
Taysha Gene Therapies, Inc.
This page
|
43,500 | $296,235 | |
| 4 | IMRX |
Immuneering Corp
|
24,245 | $120,982 | |
| 5 | IOVA |
Iovance Biotherapeutics, Inc.
|
27,998 | $116,471 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
10,000 | $87,550 | |
| 7 | OVID |
Ovid Therapeutics Inc.
|
26,000 | $69,940 | |
| 8 | ABUS |
Arbutus Biopharma Corp
|
14,000 | $67,200 |
All Filings in TSHA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $296,235 | 43,500 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $194,445 | 43,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $239,250 | 43,500 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $93,195 | 28,500 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $65,835 | 28,500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $39,615 | 28,500 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $49,305 | 28,500 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||